P010 Incidence and risk factors of secondary myelodysplastic syndrome/acute leukemia occurrence following peripheral blood progenitor cell autograft: a GITIL (Gruppo Italiano Terapie Innovative Nei Linfomi) survey on 1266 lymphoma patients
Manuela Zanni(Fondazione IRCCS Istituto Nazionale dei Tumori), Corrado Tarella(A. O. Ordine Mauriziano di Torino), Andrea Gallamini(Centre Antoine Lacassagne), Mario Boccadoro(Fondazione Gimema Onlus), Fabio Ciceri(Vita-Salute San Raffaele University), S Cortelazzo, Paolo Corradini(Gruppo di Ricerca Geriatrica), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), K. Patti, Fabio Benedetti(Azienda Ospedaliera Universitaria Integrata Verona), Ignazio Majolino, A Andreini, Roberto Passera(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Rosalba Rosato(Tumori Foundation), T Barbui, Salvatore Mirto(Ospedale Vincenzo Cervello), M. Viola Magni, AM Gianni
Cited by 1
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
|New England Journal of Medicine|2009|1k